vs

Side-by-side financial comparison of ResMed (RMD) and Sensata Technologies Holding plc (ST). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $934.8M, roughly 1.5× Sensata Technologies Holding plc). ResMed runs the higher net margin — 27.6% vs 9.3%, a 18.3% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 2.6%). Over the past eight quarters, ResMed's revenue compounded faster (7.9% CAGR vs -5.0%).

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

Sensata Technologies Holding plc is a global industrial technology company that designs, manufactures and sells a broad portfolio of sensing, electrical protection and control solutions. Its products serve automotive, industrial, aerospace, HVAC, telecommunications and heavy vehicle end markets, catering to manufacturing and enterprise clients across the world.

RMD vs ST — Head-to-Head

Bigger by revenue
RMD
RMD
1.5× larger
RMD
$1.4B
$934.8M
ST
Growing faster (revenue YoY)
RMD
RMD
+8.4% gap
RMD
11.0%
2.6%
ST
Higher net margin
RMD
RMD
18.3% more per $
RMD
27.6%
9.3%
ST
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.9%
-5.0%
ST

Income Statement — Q4 FY2026 vs Q1 FY2026

Metric
RMD
RMD
ST
ST
Revenue
$1.4B
$934.8M
Net Profit
$392.6M
$87.1M
Gross Margin
61.8%
30.6%
Operating Margin
34.6%
15.1%
Net Margin
27.6%
9.3%
Revenue YoY
11.0%
2.6%
Net Profit YoY
13.9%
24.6%
EPS (diluted)
$2.68
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RMD
RMD
ST
ST
Q2 26
$1.4B
Q1 26
$934.8M
Q4 25
$1.4B
$917.9M
Q3 25
$1.3B
$932.0M
Q2 25
$1.3B
$943.4M
Q1 25
$1.3B
$911.3M
Q4 24
$1.3B
$907.7M
Q3 24
$1.2B
$982.8M
Net Profit
RMD
RMD
ST
ST
Q2 26
$392.6M
Q1 26
$87.1M
Q4 25
$392.6M
$63.2M
Q3 25
$348.5M
$-162.5M
Q2 25
$379.7M
$60.7M
Q1 25
$365.0M
$69.9M
Q4 24
$344.6M
$5.8M
Q3 24
$311.4M
$-25.0M
Gross Margin
RMD
RMD
ST
ST
Q2 26
61.8%
Q1 26
30.6%
Q4 25
61.8%
29.0%
Q3 25
61.5%
27.8%
Q2 25
60.8%
30.3%
Q1 25
59.3%
29.9%
Q4 24
58.6%
27.1%
Q3 24
58.6%
28.6%
Operating Margin
RMD
RMD
ST
ST
Q2 26
34.6%
Q1 26
15.1%
Q4 25
34.6%
10.9%
Q3 25
33.4%
-13.2%
Q2 25
33.7%
14.6%
Q1 25
33.0%
13.4%
Q4 24
32.5%
8.1%
Q3 24
31.6%
-20.3%
Net Margin
RMD
RMD
ST
ST
Q2 26
27.6%
Q1 26
9.3%
Q4 25
27.6%
6.9%
Q3 25
26.1%
-17.4%
Q2 25
28.2%
6.4%
Q1 25
28.3%
7.7%
Q4 24
26.9%
0.6%
Q3 24
25.4%
-2.5%
EPS (diluted)
RMD
RMD
ST
ST
Q2 26
$2.68
Q1 26
$0.59
Q4 25
$2.68
$0.45
Q3 25
$2.37
$-1.12
Q2 25
$2.58
$0.41
Q1 25
$2.48
$0.47
Q4 24
$2.34
$0.05
Q3 24
$2.11
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RMD
RMD
ST
ST
Cash + ST InvestmentsLiquidity on hand
$1.4B
$635.1M
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$6.3B
$2.9B
Total Assets
$8.5B
$6.8B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RMD
RMD
ST
ST
Q2 26
$1.4B
Q1 26
$635.1M
Q4 25
$1.4B
$573.0M
Q3 25
$1.4B
$791.3M
Q2 25
$1.2B
$661.8M
Q1 25
$932.7M
$588.1M
Q4 24
$521.9M
$593.7M
Q3 24
$426.4M
$506.2M
Total Debt
RMD
RMD
ST
ST
Q2 26
$663.8M
Q1 26
Q4 25
$403.9M
$2.8B
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$662.9M
$3.2B
Q3 24
$667.6M
Stockholders' Equity
RMD
RMD
ST
ST
Q2 26
$6.3B
Q1 26
$2.9B
Q4 25
$6.3B
$2.8B
Q3 25
$6.1B
$2.7B
Q2 25
$6.0B
$2.9B
Q1 25
$5.5B
$2.8B
Q4 24
$5.3B
$2.9B
Q3 24
$5.2B
$3.0B
Total Assets
RMD
RMD
ST
ST
Q2 26
$8.5B
Q1 26
$6.8B
Q4 25
$8.5B
$6.8B
Q3 25
$8.3B
$7.1B
Q2 25
$8.2B
$7.3B
Q1 25
$7.6B
$7.2B
Q4 24
$7.1B
$7.1B
Q3 24
$7.2B
$7.3B
Debt / Equity
RMD
RMD
ST
ST
Q2 26
0.11×
Q1 26
Q4 25
0.06×
1.02×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
1.11×
Q3 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RMD
RMD
ST
ST
Operating Cash FlowLast quarter
$122.5M
Free Cash FlowOCF − Capex
$104.6M
FCF MarginFCF / Revenue
11.2%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$508.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RMD
RMD
ST
ST
Q2 26
Q1 26
$122.5M
Q4 25
$339.7M
$201.5M
Q3 25
$457.3M
$159.9M
Q2 25
$538.8M
$140.9M
Q1 25
$578.7M
$119.2M
Q4 24
$308.6M
$170.7M
Q3 24
$325.5M
$130.9M
Free Cash Flow
RMD
RMD
ST
ST
Q2 26
Q1 26
$104.6M
Q4 25
$311.2M
$151.9M
Q3 25
$414.4M
$136.2M
Q2 25
$508.2M
$115.5M
Q1 25
$557.9M
$86.6M
Q4 24
$288.0M
$138.9M
Q3 24
$307.7M
$91.3M
FCF Margin
RMD
RMD
ST
ST
Q2 26
Q1 26
11.2%
Q4 25
21.9%
16.6%
Q3 25
31.0%
14.6%
Q2 25
37.7%
12.2%
Q1 25
43.2%
9.5%
Q4 24
22.5%
15.3%
Q3 24
25.1%
9.3%
Capex Intensity
RMD
RMD
ST
ST
Q2 26
Q1 26
Q4 25
2.0%
5.4%
Q3 25
3.2%
2.5%
Q2 25
2.3%
2.7%
Q1 25
1.6%
3.6%
Q4 24
1.6%
3.5%
Q3 24
1.5%
4.0%
Cash Conversion
RMD
RMD
ST
ST
Q2 26
Q1 26
1.41×
Q4 25
0.87×
3.19×
Q3 25
1.31×
Q2 25
1.42×
2.32×
Q1 25
1.59×
1.70×
Q4 24
0.90×
29.50×
Q3 24
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons